AJG vs AVDL · P/E 33, rev $8.76B vs rev $169.1M
Arthur J Gallagher & Co (AJG) versus Avadel Pharmaceuticals PLC (AVDL) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. AVDL currently screens at market cap $968.5M.
Not investment advice. Open the AJG and AVDL stock pages for the full models.
Not investment advice.